The Impact of Biophoton Therapy on Self-Grown Stem Cells
A Randomized Double Blinded and Placebo-Controlled Trial to Assess the Impact of Biophoton Therapy on Self-Grown Stem Cells
First Institute of All Medicines
46 participants
Feb 10, 2025
INTERVENTIONAL
Conditions
Summary
Study Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing® Biophoton Generators (Biophotonizer), can increase self-grown stem cells naturally. Study Design This is a randomized, double-blinded, placebo-controlled intervention clinical study to assess the effectiveness of biophoton therapy in impacting stem cells. Approximately 46 volunteers who want to increase self-grown stem cells will participate in the study. Study Randomization The biostatistician will prepare a randomization schedule including a serial of subject numbers. A subject number will be randomly assigned to each study participant, which will assign them to either the control group or the treatment group. Other than the Informed Consent Form (ICF), all study information will be recorded by using the subject number. The Principal Investigator, study physicians, study nurse, data-entry specialists, and biostatisticians, as well as the participants, will be blinded about who received which product during the first two weeks of study participation.
Eligibility
Inclusion Criteria5
- Willing and able to give informed consent for participation in the trial.
- Is able and willing to comply with all trial requirements.
- Male or female ages 18-70 years old without major diseases.
- Participants must not be heavy users of Tesla BioHealing devices; enrollment will be determined by the clinical team based on an evaluation of the participant's prior device usage.
- Must be fluent in English.
Exclusion Criteria3
- Untreated psychiatric disturbances that would affect trial participation as judged by the research medical professional.
- Is participating in another investigational drug or device trial
- Had been treated with Stem Cell therapy within a 6-month period.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Users will be receiving biophotons emitted from the 4 devices during sleep and other time.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06855459